The global humanized liver mice model market is projected to experience significant growth over the coming years, with the market value expected to reach an estimated USD 178 million by 2033, up from USD 104 million in 2024. This growth reflects a compound annual growth rate (CAGR) of 5.6% during the forecast period from 2024 to 2033. This press release offers a comprehensive overview of the market's forecast, insights, key growth determinants, barriers, trends, opportunities, and a regional and competitive landscape analysis.
šš„š¢šš¤ ššš«š š šØš« ššØš«š: https://www.fairfieldmarketresearch.com/report/humanized-liver-mice-model-market Market Overview and Growth Dynamics Humanized liver mice models have emerged as a promising alternative to conventional animal models, especially in research focused on liver diseases. The human liver is a critical organ that serves as a reservoir for various significant pathogens, leading to nearly half a billion infections annually and causing between 2.5 and 4.5 million fatalities worldwide. Humanized liver mice models are increasingly utilized to study the progression of liver diseases and evaluate potential therapeutic interventions. Researchers have been focusing on developing more advanced liver mouse models that closely replicate human physiology. Initially, liver mouse models were developed through the transplantation of human liver cells or hepatic cancer cells into immunocompromised mice. However, the outcomes of these early models often displayed irregularity and lack of dependability. To address these challenges, researchers have developed mice with weakened immune systems that naturally destroy their livers. This destruction allows human liver cells to grow and replace the original liver, leading to the development of more stable and reliable humanized liver models.